生命科学资讯

BridgeBio preps approval push after dwarfism drug increases children's height in phase 3

Langer-backed biotech looks to end cancer recurrence with surgical revolution

Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval

Seres to lay off 30% of employees, pause lead program in latest strategic shift

Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma

European VCs join forces to boost flagging biotech investment in the region

UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing

Takeda downsizes Boston footprint amid consolidation effort

‘The only thing that saves us is data’: Allogeneic CAR-T biotechs fight for relevance as industry moves on

Upstream posts Tezspire-like asthma efficacy in phase 2 but falls short of best-case scenario

Madrigal pens $4.4B deal for Ribo's preclinical siRNA programs in latest Rezdiffra MASH play

GE HealthCare debuts tech to help hospitals remotely maintain bedside ECG stations

Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale

Kailera, Hengrui tout up to 12% weight loss in midstage study for obesity pill

Evommune's Dupixent-like phase 2 eczema data drive 75% stock rally

Merck teams up with British medtech to boost vaginal therapeutics delivery system

AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data

Nektar eczema candidate 'checked all of the boxes' in long-term phase 2 data

Bristol Myers and Evinova pen global development partnership

FDA rejects Regenxbio's gene therapy in Hunter syndrome, leaving CEO 'concerned'